Cart
sales@molnova.com
Fmoc-Gly-Thr(psi(Me,Me)pro)-OH
CAS No. 1262308-49-5
Fmoc-Gly-Thr(psi(Me,Me)pro)-OH( —— )
Catalog No. M28196 CAS No. 1262308-49-5
Fmoc-Gly-Thr(psi(Me,Me)pro)-OH is a dipeptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 47 | In Stock |
|
| 50MG | 27 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFmoc-Gly-Thr(psi(Me,Me)pro)-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionFmoc-Gly-Thr(psi(Me,Me)pro)-OH is a dipeptide.
-
DescriptionFmoc-Gly-Thr(psi(Me,Me)pro)-OH is a dipeptide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNGF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1262308-49-5
-
Formula Weight438.48
-
Molecular FormulaC24H26N2O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (570.16 mM)
-
SMILESC[C@H]1OC(C)(C)N([C@@H]1C(O)=O)C(=O)CNC(=O)OCC1c2ccccc2-c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arkin MR, et al. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004 Apr;3(4):301-17.
molnova catalog
related products
-
threo-7,9,9-Trihydro...
The herbs of Leucaena leucocephala.
-
MitoPQ
MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter.
-
Dihydroxyfumaric aci...
Dihydroxyfumaric acid is a known generator of superoxide anions and by hydroxyl free radicals. Dihydroxyfumarate exposure can cause insulin inhibitory effects. It can spontaneously convert to hydroxypyruvate or to oxaloglycolate.
